RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bharat Immunologicals and Biologicals Corporation - Stock

Bharat Immunologicals and Biologicals Corporation Debt 2024

Bharat Immunologicals and Biologicals Corporation Debt

614.81 INR

Ticker

524663.BO

ISIN

INE994B01014

In 2024, Bharat Immunologicals and Biologicals Corporation's total debt was 614.81 INR, a -5.23% change from the 648.76 INR total debt recorded in the previous year.

Bharat Immunologicals and Biologicals Corporation Aktienanalyse

What does Bharat Immunologicals and Biologicals Corporation do?

Bharat Immunologicals and Biologicals Corporation ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Bharat Immunologicals and Biologicals Corporation's Debt Structure

Bharat Immunologicals and Biologicals Corporation's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Bharat Immunologicals and Biologicals Corporation's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Bharat Immunologicals and Biologicals Corporation’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Bharat Immunologicals and Biologicals Corporation’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Bharat Immunologicals and Biologicals Corporation stock

What is the debt of Bharat Immunologicals and Biologicals Corporation this year?

Bharat Immunologicals and Biologicals Corporation has a debt level of 614.81 INR this year.

What was the debt of Bharat Immunologicals and Biologicals Corporation compared to the previous year?

The debt of Bharat Immunologicals and Biologicals Corporation has increased by -5.23% compared to the previous year dropped.

What are the consequences of high debt for investors in Bharat Immunologicals and Biologicals Corporation?

High debt can pose a risk for investors of Bharat Immunologicals and Biologicals Corporation, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Bharat Immunologicals and Biologicals Corporation?

Low debt means that Bharat Immunologicals and Biologicals Corporation has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Bharat Immunologicals and Biologicals Corporation affect the company?

An increase in debt of Bharat Immunologicals and Biologicals Corporation can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Bharat Immunologicals and Biologicals Corporation affect the company?

A reduction in debt of Bharat Immunologicals and Biologicals Corporation can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Bharat Immunologicals and Biologicals Corporation?

Some factors that can influence the debt of Bharat Immunologicals and Biologicals Corporation include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Bharat Immunologicals and Biologicals Corporation so important for investors?

The debts of Bharat Immunologicals and Biologicals Corporation are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Bharat Immunologicals and Biologicals Corporation take to change the debt?

To change the debt, Bharat Immunologicals and Biologicals Corporation can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Bharat Immunologicals and Biologicals Corporation pay?

Over the past 12 months, Bharat Immunologicals and Biologicals Corporation paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bharat Immunologicals and Biologicals Corporation is expected to pay a dividend of 0 INR.

What is the dividend yield of Bharat Immunologicals and Biologicals Corporation?

The current dividend yield of Bharat Immunologicals and Biologicals Corporation is .

When does Bharat Immunologicals and Biologicals Corporation pay dividends?

Bharat Immunologicals and Biologicals Corporation pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bharat Immunologicals and Biologicals Corporation?

Bharat Immunologicals and Biologicals Corporation paid dividends every year for the past 0 years.

What is the dividend of Bharat Immunologicals and Biologicals Corporation?

For the upcoming 12 months, dividends amounting to 0 INR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bharat Immunologicals and Biologicals Corporation located?

Bharat Immunologicals and Biologicals Corporation is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bharat Immunologicals and Biologicals Corporation kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bharat Immunologicals and Biologicals Corporation from 7/4/2024 amounting to 0 INR, you needed to have the stock in your portfolio before the ex-date on 7/4/2024.

When did Bharat Immunologicals and Biologicals Corporation pay the last dividend?

The last dividend was paid out on 7/4/2024.

What was the dividend of Bharat Immunologicals and Biologicals Corporation in the year 2023?

In the year 2023, Bharat Immunologicals and Biologicals Corporation distributed 0 INR as dividends.

In which currency does Bharat Immunologicals and Biologicals Corporation pay out the dividend?

The dividends of Bharat Immunologicals and Biologicals Corporation are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Bharat Immunologicals and Biologicals Corporation

Our stock analysis for Bharat Immunologicals and Biologicals Corporation Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bharat Immunologicals and Biologicals Corporation Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.